Kristin Yarema
Chief Commercial Officer, Atara Biotherapeutics, Inc.
Companies
- ImageneBio, Inc.Board member Jul 29, 2025 to now1
- ImageneBio, Inc.Chief executive officer Jul 29, 2025 to now1
- Poseida Therapeutics, Inc.Chief executive officer Jan 4, 2024 to Jan 8, 20252
- Poseida Therapeutics, Inc.President Apr 12, 2023 to Jan 8, 20253
- Poseida Therapeutics, Inc.Board member Jan 4, 2024 to Jan 4, 20242
- Atara Biotherapeutics, Inc.Chief Commercial Officer Feb 19, 2020 to Mar 3, 20224
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ImageneBio, Inc. IMA493,705 shares5$2.0M at $4.05Aug 14, 2026
- Atara Biotherapeutics, Inc. ATRA171,415 shares6$1.6M at $9.24Mar 1, 2022
- Poseida Therapeutics, Inc.0 shares7Jan 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 14, 2026Granted 254,800 shares of ImageneBio, Inc.5
- Jul 25, 2026Other 115,129 shares of ImageneBio, Inc.8
- Jul 25, 2026Exercised options 38,376 shares of ImageneBio, Inc.8
- Mar 16, 2026Granted 85,400 shares of ImageneBio, Inc.9
- Jan 8, 2025U 615,836 shares of Poseida Therapeutics, Inc.7
- Jan 2, 2024Granted 250,000 shares of Poseida Therapeutics, Inc.10
- Apr 11, 2023Granted 356,836 shares of Poseida Therapeutics, Inc.11
- Mar 1, 2022Granted 45,533 shares of Atara Biotherapeutics, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARImageneBio, Inc., Board member
- 2
- 3
- 4
- 5
- 6
- 7
- 8SEC EDGARForm 4 filed Jul 28, 2026
- 9SEC EDGARForm 4 filed Mar 18, 2026
- 10SEC EDGARForm 4 filed Jan 4, 2024
- 11SEC EDGARForm 4 filed Apr 12, 2023